Most Popular Stories
- Ben Venue can't say when crucial cancer drug will be available
- Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
- Ben Venue's idled plant triggers 'dire' leukemia-drug shortage
- Novartis dealt another setback to broader Menveo use
- Curcumin, in Indian curry spice, may beat down prostate tumors
- Key protein appears to kill off HIV food supply in certain cells
- GSK studies Chinese remedies to discover new drugs
- Chelsea shares nosedive on FDA's questions about key drug
- DNA sequencing exposes new uses for Pfizer targeted cancer drugs
- Preclinical study triggers 'massive response' from desperate Alzheimer's patients
- Hungry Valeant snags Eyetech in ongoing buyout spree
Webinars
- Inside the mHealth Revolution with Welch Allyn: Realizing the Potential of Connected DevicesAfter launching a line of connected devices, Welch Allyn immediately viewed it as an oppor
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
Featured Jobs
-
Manager, Business Development
Clinical Resource Network - Chicago, IL -
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Facilities Project Manager
Genomics Institute of the Novartis Research Foundation - San Diego, CA -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
District Sales Manager – Hematology, Denver / Phoenix Job
Celgene Corporation - Denver, CO, US
Events
- Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York - BioNetwork East: Key BioPharma Partnering Conference
March 5-7 2012 — Miami, Florida - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Otava Lead-Like Library
- The FDA Review Process: a Technical Look
- The National Provider Identifier (NPI) and its Impact on the Pharmaceutical and Medical Device Industries
- Role of Micro Blogging in Search Engine Marketing
- Commercial Insight: Top 20 Cancer Therapy Brands
- Meeting the Unmet Medical Needs and the Training Imperative
Biography for Maureen Martino
Maureen Martino is the managing editor of the FierceMarkets Life Sciences group and a contributor to FierceBiotech and FierceMedicalDevices. She is a graduate of Franklin & Marshall College in Lancaster, PA. Prior to joining FierceMarkets in 2005, she was an intern at Johnson & Johnson's business development unit and quality control and compliance group. Maureen is passionate about covering emerging live science companies, breakthrough technologies and biopharma M&A. She loves traveling, reading, cooking and is a classically-trained pianist. Maureen is based in the Philadelphia area, and can be reached at maureen@fiercemarkets.com. You can follow her at @FierceBiotech on Twitter and find her on LinkedIn.
Articles by Maureen Martino
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- January 17, 2012
- December 2, 2011
- December 2, 2011
- November 30, 2011
- November 29, 2011
- November 29, 2011
- November 28, 2011
- November 28, 2011
- November 28, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
